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Abstract We report data from a randomised controlled trial
of mindfulness-based cognitive therapy to pilot procedures
for people with a history of suicidal ideation or behaviour,
focusing in particular on the variables that distinguish those
who complete an adequate ‘dose’ of treatment, from those
who drop out. Sixty-eight participants were randomised to
either immediate treatment with mindfulness-based cogni-
tive therapy (MBCT) (n=33) or to the waitlist (n=36) arm
of the trial. In addition to collecting demographic and
clinical information, we assessed participants’ cognitive
reactivity using the means end problem-solving task,
completed before and after a mood induction procedure.
Ten participants dropped out of treatment, and eight
dropped out of the waitlist condition. Those who dropped
out of MBCT were significantly younger than those who
completed treatment, less likely to be on antidepressants,
had higher levels of depressive rumination and brooding
and showed significantly greater levels of problem-solving
deterioration following mood challenge. None of these
factors distinguished participants in the waiting list condi-
tion who remained in the study from those who dropped
out. Our results suggest that individuals with high levels of
cognitive reactivity, brooding and depressive rumination
may find it particularly difficult to engage with MBCT,
although paradoxically they are likely to have the most to
gain from the development of mindfulness skills if they
remain in class. Addressing how such patients can be best
prepared for treatment and supported to remain in treatment
when difficulties arise is an important challenge.
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Introduction
Mindfulness-based cognitive therapy (MBCT) is a manual-
ised group-based treatment programme, which combines
cognitive therapy with intensive training in mindfulness
meditation, and was designed to be delivered to patients in
recovery from major depression. Two previous trials of
MBCT for recurrent depression have demonstrated that the
treatment significantly reduces the risk of relapse over a
12-month period in those with three or more depressive
episodes (Ma and Teasdale 2004; Teasdale et al. 2000),
with a more recent trial demonstrating that MBCT has
equivalent results to continuation antidepressant medication
over a 1-year follow-up (Kuyken et al. 2008).
Although these trials of MBCT have based their out-
comes on intention-to-treat analysis, it is notable that across
the three studies, 17%, 16% and 15% of participants
allocated to MBCT dropped out before receiving an
adequate dose of treatment (four sessions), with approxi-
mately half in each case dropping out before receiving any
treatment sessions at all. Although these levels of dropout
compare favourably with dropout from treatment trials for
patients with acute depression (e.g. Evans et al. 1992, 40%
attrition by 12 weeks for antidepressants and/or cognitive
therapy; Warden et al. 2009, Star*D, 27% attrition by
12 weeks for antidepressant treatment) and dropout from
cognitive behavioural therapy (CBT) as part of routine
clinical practice (22.5% of 1,646 patients offered CBT in an
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Kirk 2005) understanding the factors which influence
attrition from MBCT is nevertheless important, particularly
if is to be utilised with harder-to-treat clinical groups,
including those with a more severe history or those with
more residual symptoms, where expected levels of attrition
would be higher.
We are particularly interested in issues of retention in
treatment since our research is concerned with the use of
mindfulness-based cognitive therapy for patients who have a
history of suicidal ideation or behaviour. Although MBCT
may hold promise for these patients (e.g. Williams et al.
2006), difficulties with engagement and retention in treat-
ment can be pronounced. For example, in the POPMACT
trial of brief CBT for suicide attempters, 38% of those
allocated to CBT treatment failed to attend even one
treatment session (Tyrer et al. 2003). Rudd et al. (1996)
found a 21% drop-out rate in a treatment study of young
suicidal adults. Although this appears to be comparatively
low, patients were enrolled in a 2-week intensive partial
hospitalisation intervention, which is likely to have increased
compliance above levels seen in outpatient studies. Finally
Brown et al. (2005) managed to retain almost all the
participants in their trial of cognitive therapy for suicide
attempters (only two out of 60 did not attend cognitive
therapy) but did so in the context of very intensive efforts
including the use of study case managers. The ability to
provide two verified contacts to assist with tracking and
retention was included as a pre-requisite of entry to the trial,
after pilot work indicated that dropout was otherwise likely
to pose a significant threat to the study (Henriques, personal
communication, 2004).
The three previous trials of MBCT for recurrent
depression have all examined socio-demographic and
clinical history variables, which might explain the causes
of attrition from treatment. Two factors were found to
distinguish dropouts from MBCT from those who remained
in treatment: having a history of two, rather than three or
more episodes of depression (associated with increased
likelihood of dropout; Ma and Teasdale 2004) and having a
history of attempted suicide (associated with increased
likelihood of dropout; Kuyken et al. 2008). No other
baseline variables distinguished the groups. Studies of
meditation-based stress reduction (MBSR) programmes
have also identified relatively few factors, which predict
dropout. For example, Kabat-Zinn and Chapman-Waldrop
(1988) reviewed adherence in a standard 8-week MBSR
programme over a 2-year period and found an average
completion rate of 76%, with 9% attending no sessions and
a further 15% dropping out after the beginning of the
programme, usually within the first few weeks (a pattern
very similar to that observed in MBCT). Amongst patients
referred for chronic pain, gender (being male), but not pain
severity, chronicity or global distress (SCL-90), differen-
tiated those who dropped out of treatment from those who
remained. Amongst patients referred for stress-related
complaints, only the obsessive-compulsive symptoms sub-
scale of the SCL-90 differentiated groups (those higher in
obsessive-compulsive symptoms being more likely to
complete treatment). Similarly Carmody and Baer (2008)
reported drop-out figures for participants attending MBSR
classes at the University of Massachusetts Medical School
in 2006 who consented to participate in a research study
exploring the effects of home practice on outcome.
Participants who dropped out (5%, n=10) or failed to
provide post-treatment measures (11%, n=22) did not differ
from those who completed the study protocol on the
measured socio-demographic factors, nor on baseline
measures of medical and psychological symptom severity,
perceived stress, well being or mindfulness.
It is important to note that many of the variables that
have been explored in relation to dropout concern socio-
demographic factors or clinical history. Even if such
variables are found to distinguish dropouts from treatment
completers, they represent things which, by their very
nature, cannot be changed. If, on the other hand, we could
identify psychological process variables which render a
person at increased risk of dropout, these might give an
indication of how best to prepare patients for challenges
they will face when beginning treatment. For example
Lynch (2004) examined factors associated with adherence
to MBSR amongst women with fibromyalgia. Sixty-nine
percent of participants attended at least five out of the eight
treatment sessions with only emotional role functioning
predicting attendance at treatment sessions: Those parti-
cipants who reported that emotional problems interfered
more with their ability to function in daily life attended
fewer sessions, suggesting that where problems in daily
functioning are identified, these are likely to impact upon
the ability to fully participate in treatment.
MBCT is designed to be delivered to patients in
remission from major depression. The intention is that
patients have the opportunity to practice cultivating non-
judgemental awareness in relation to relatively innocuous
thoughts, feelings and body sensations, before attempting to
apply this same mode of processing to negative mental
content. From the first session onwards, meditation practi-
ces are used to bring participants into direct contact with
their moment to moment experience in order to develop
their capacities to attend to and accept their experience.
However for those who may have ruminated about or tried
to suppress negative thoughts and feelings over many years,
the prospect of adopting such a radically different approach
may be daunting. Indeed, for some, negative thoughts and
feelings may be very ‘close to the surface’, and these
patients may be immediately confronted with challenging
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(1998), in a review of adherence in MBSR programmes,
report that one study found that chronic pain patients who
experienced anxiety more somatically preferred the most
‘cognitive’ form of meditation (e.g. sitting), whilst those
who tended to experience anxiety mainly as a cognitive
phenomenon preferred more active forms of meditation
(e.g. walking and yoga). This is consistent with the idea
that participants may, at least initially, find it easier to
engage with meditation practices that bring them into less
close contact with their core aversive experiences. If this is
the case, then the ability to identify people who are likely to
find classes challenging and tailor the programme more
specifically to their needs, or prepare them better for what
they are likely to experience when they begin meditating,
would be very beneficial. However none of the studies of
MBCT to date have examined whether psychological
process variables, which might capture such difficulties,
are able to predict attrition from treatment.
Two such variables, which might predict difficulty in
engaging with MBCT, are high levels of cognitive
reactivity and a tendency to engage in rumination. Whilst
many patients with a history of depression show evidence
of cognitive reactivity—the rapid reactivation of depresso-
genic cognitive patterns under conditions of low mood—it
appears that this cognitive profile is particularly pro-
nounced in patients with a history of suicidality, where it
extends to behavioural problems as well as to the
reactivation of dysfunctional beliefs. For example Williams
et al. (2005) studied the effects of induced negative mood
on interpersonal problem-solving performance in parti-
cipants with a history of depression with or without suicidal
ideation, as well as in healthy controls. All three participant
groups were indistinguishable in their problem-solving
performance at baseline. However following the negative
mood induction, previously suicidal participants showed a
significant reduction in problem-solving effectiveness,
whilst the performance of the other two groups remained
relatively unchanged. The reactivation of problem-solving
impairments in response to minor fluctuations in negative
mood might readily undermine a patient’s commitment to
relatively intensive psychological treatment, and might also
be a marker of more generally elevated levels of cognitive
reactivity
There is growing evidence that suicidality is also
associated with increased levels of rumination (see
Morrison and O’Connor 2008 for a systematic review of
the literature in this area). This might be important in
understanding attrition for two reasons. Firstly, because
rumination is likely to involve the rehearsal of depresso-
genic cognitions, the more an individual ruminates, the
more accessible, habitual and toxic these negative cogni-
tions are likely to become, making them more likely to
emerge early during meditation, when cognitive control is
relinquished. Secondly, rumination and mindful observation
of experience are in some ways opposite states, so habitual
ruminators are likely to find it particularly difficult to adjust
to this approach, although paradoxically it might have the
most to offer them.
In order to examine whether these cognitive variables
might be related to attrition from treatment, we utilised data
collected from a randomised controlled trial of MBCT in
which we were exploring how best to adapt the programme
for patients with a history of suicidal depression including
those with both uni- and bipolar disorders. This trial was
conducted as a feasibility and acceptability study, and the
main outcomes have been reported elsewhere (Williams et
al. 2008, primary outcomes; Crane et al. 2008; Hepburn et
al. 2009, secondary outcomes). In this paper, we explore in
detail the clinical and cognitive factors associated with
attrition from treatment. Specifically we hypothesised that
those who dropped out of treatment would show evidence
of higher levels of cognitive reactivity, assessed by degree
of deterioration in problem-solving effectiveness following
induction of negative mood (Williams et al. 2005), and
higher levels of rumination as assessed by the ruminative
responses scale (Treynor et al. 2003). Importantly, because
these data were collected from a randomised controlled
trial, we were able to examine whether factors associated
with dropout from MBCT also affected dropout of
participants allocated to the waiting list arm, or whether
they were specific to treatment.
Methods
Inclusion/Exclusion Criteria
The primary inclusion criteria for the trial were the presence
of at least one past episode of MDD and a history of active
suicidal ideation (suicidal thoughts including thoughts of
methods of suicide) or a suicide attempt. We required
individuals to be well at entry to the trial, reporting no more
than 1 week of minimal symptoms of MDD in the past
8 weeks. Individuals with schizophrenia, obsessive-
compulsive disorder, current eating disorder or marked
alcohol or substance misuse problems (to an extent that
would preclude attendance at classes) or difficulties
reading, writing or speaking fluent English were excluded,
as were those aged under 18 or over 65 years. Individuals
with bipolar disorder were eligible to take part so long as
they had not experienced a manic/hypomanic episode
within the past 6 months. We did not impose restrictions
concerning current medication use but individuals who had
received past CBT were excluded unless they had experi-
enced a relapse to MDD since their last session of CBT.
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Participants were recruited through posters, newspaper
articles and features in the local media, which invited
individuals who had been depressed and suicidal in the past,
but who were currently feeling better, to contact the research
team to take part in a clinical trial of a new psychological
treatment to help people stay well. Having read the
information sheet and additional information about the trial,
125 individuals expressed an interest in taking part and
underwent telephone screening to assess eligibility in terms
of the study inclusion/exclusion criteria outlined above.
Forty-two individuals were excluded at this point due to
ineligibility (20 experiencing current depression/suicidal
ideation, four experiencing current mania/hypomania, nine
due to recent CBT, three because they had not experienced
suicidal ideation or behaviour of sufficient severity in the
past and six for other reasons that would have made the
classes or assessments unsuitable; e.g. Asperger syndrome
and learning difficulties). Eighty-three individuals were
judged eligible to take part and were invited to attend the
Department of Psychiatry for a more detailed screening
interview andthecompletionofquestionnairesandcognitive
tasks. Of these individuals, 11 did not attend their first
assessment, two were judged to be ineligible following more
detailed screening (one due to current psychotic symptoms
and one due to aggression and current suicidal ideation), and
two withdrew themselves from the study before completing
all the assessment measures. This left 68 individuals who
enteredthetreatmenttrialandwererandomisedtoimmediate
or delayed treatment (see below). The flow of participants
through the trial is shown in Fig. 1.
Design and Procedure
Following recruitment, participants attended the Department
of Psychiatry for a detailed screening assessment. During
this assessment, we obtained information on psychiatric
history and current psychiatric disorders. Individuals also
completed a number of questionnaires and several cognitive
tasks including the means end problem-solving task (Platt
et al. 1978) and a Word Fluency Task (Lezak 1976). Both
these tasks were administered before and after a negative
mood induction. Following completion of the first assess-
ment, we randomly allocated eligible participants to imme-
diate or delayed treatment. Those participants randomised to
immediate treatment were invited to attend an introductory
meeting with the psychologist running their classes. Those
who were randomised to delayed treatment were informed
that the research team would be keeping in touch with them
periodically by letter during the waiting period and that they,
like those receiving immediate treatment, would be asked to
attend the Department of Psychiatry for a second assessment
session. Following the completion of the classes or waiting
period, all participants who could be contacted were invited
back to attend a second assessment session during which
they completed the same questionnaires and cognitive tasks
as at baseline. Participants’ full travel expenses to attend both
research assessments and treatment were reimbursed. Addi-
tionally participants received £10 per research assessment
attended in recognition of the time commitment participation
entailed.
Retention Efforts
Where a patient failed to attend a treatment session,
therapists attempted to contact the patient by telephone,
email and if necessary by letter to re-establish contact and
retain the person in treatment. Where a participant failed to
attend a session, we sent them materials by post, and
invited them to continue practicing at home. At the end of
the treatment or waiting period, extensive efforts were made
to contact all participants, both those allocated to MBCT
and those allocated to the waitlist arm by letter, telephone
and email to schedule appointments. A dropout was defined
as someone who failed to attend at least four classes for
those allocated to MBCT or failed to provide any data for
Initial
contact and
screening
n = 125 
Ineligible or not 
interested
n = 42 
Did not attend  n=11
Ineligible n=2
Withdrew n=2
Invited for 
assessment
n = 83 
Randomization
n = 68 
MBCT
n = 33 
Waitlist
n = 35 
Drop-out
n = 10 
Completer
n = 23 
Drop-out
n = 8 
Completer
n = 27 
Fig. 1 Flow of participants through the trial.
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list condition.
Randomisation
Randomisationwasstratifiedaccordingtonumberofprevious
episodes of MDD (<3 or 3+) and history of suicidality
(ideationorattempt).Randomisationenvelopeswereprepared
and sealed by an individual outside the research team, and
randomisation was conducted by a member of the team blind
to the interpretation of the stratification numbers. Thirty three
of the participants were randomised to receive immediate
treatment, and 35 were randomised to receive delayed
treatment. Participants were informed of the outcome of
randomisation by letter following completion of all initial
assessments.
Measures
Clinical Interview At the first assessment, participants were
screened using the Mini International Neuropsychiatric
Interview (MINI; Sheehan et al. 1998) and the Structured
Clinical Interview for DSM-IVAxis II (SCID-II) borderline
personality disorder module (First et al. 1997). The MINI is
a structured interview, which provides DSM-IV diagnoses
of Axis I psychiatric disorders, and has excellent reliability
when compared to diagnoses derived from the SCID
(Sheehan et al. 1998).
Beck Depression Inventory (Beck et al. 1996) The Beck
Depression Inventory (BDI-II) is a well-established mea-
sure of depressive symptomatology that contains 21 groups
of statements, referring to the presence of symptoms of
depression over the preceding 2 weeks.
Beck Anxiety Inventory (Beck and Steer 1990) The Beck
Anxiety Inventory (BAI) is a 21-item self-report question-
naire that measures the common symptoms of anxiety. The
scale is reliable and valid and is able to differentiate anxiety
from depression.
Ruminative Responses Subscale (Nolen-Hoeksema and Morrow
1990; Treynor et al. 2003) The Ruminative Responses
Subscale (RRS) consists of three subscales assessing how
people react when feeling low or depressed: depression-
related rumination (12 items, e.g. ‘think about feelings of
achiness and fatigue’, ‘think about how hard it is to
concentrate’), brooding (five items, described by the
authors as ‘moody pondering’ e.g. “think ‘why can’tI
handle things better?’”) and reflection (five items referring
to neutrally valenced pondering, e.g. ‘analyse recent events
to try and understand why you are depressed’; see Treynor
et al. 2003 for factor analysis).
Cognitive Reactivity Assessment
Mood Induction In order to assess the effects of negative
mood on problem solving and verbal fluency, we admin-
istered a combined mood induction. Participants listened to
Prokofiev’s ‘Russia under the Mongolian Yoke’ (Alexander
Nevsky Suite) played at half speed over a period of 8 min
whilst reading a set of 32 negative Velten statements (e.g.
‘There are things about me that I don’t like’ or ‘I just want
to curl up and go to sleep’). Mood was measured at the
beginning at end of the mood induction and the beginning
and end of the experiment using VAS scales on which
participants indicated how ‘sad’ and ‘happy’ they felt at
that moment.
Means End Problem-Solving Task (Platt et al. 1978) The
means end problem-solving task (MEPS) assesses parti-
cipants’ ability to generate effective solutions to interpersonal
problems. In order to assess problem-solving ability, parti-
cipants are presented with a problem and a desired end-point
and were given 1 min to describe the most effective way of
getting from the beginning to the end of the scenario. For the
current study, we used 12 problem-solving scenarios (to
enable assessment of problem solving through three scena-
rios pre- and post-mood induction, both before and after
treatment or waitlist), including both the traditional scenarios
from Platt and Spivak (losing a watch, making friends in a
new neighbourhood, having difficulty with a supervisor at
work, starting a relationship, resolving problems with friends
and dealing with difficulties in a romantic relationship) and
six comparable scenarios developed for the current study
(finding a new job, helping a friend who does not seem to be
their usual self, dealing with problems with an electricity
supplier, resolving problems caused by troublesome young
people in the neighbourhood, maintaining a relationship with
a platonic friend who has romantic feelings and coping with
short-term financial difficulties). Scenarios were grouped
into four blocks to ensure that each block contained a
mixture of themes (e.g. work, romantic relationships, friend-
ships, neighbourhood and practical problems). The order of
presentation of these blocks was counterbalanced across
participants, and analysis indicated no significant effects of
order of presentation on effectiveness ratings.
Previous research has shown that it is problem-solving
effectiveness, rather than number of relevant means, which
differentiates participants with a history of suicidal ideation
from those with a history of non-suicidal depression
(Williams et al. 2005). For the purposes of the current
study, effectiveness was rated on a scale ranging from 1
(not at all effective) to 7 (extremely effective) by a rater
blind to participant allocation (immediate treatment versus
waitlist) and to whether the each MEPS solution had been
completed before or after the mood induction procedure. A
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independent rater, yielding a weighted kappa of 0.76,
indicating good agreement.
Verbal Fluency Task (Lezak 1976) The Verbal Fluency
Task was administered before and after the mood induction,
to provide a control for the effects of mood on general
speed of cognitive processing. Participants were instructed
to say aloud as many words as they could think of
beginning with each of two letters FA, SD, RT or DM in
30 s without repeating words or using different versions of
the same word. The letter sets were counterbalanced across
participants and time of assessment (before and after mood
induction and before and after the treatment or waitlist
period). The total number of valid words generated by
participants was recorded on each occasion.
MBCT Classes
All participants who were randomised to MBCT were
offered a pre-class interview with the instructor who would
be leading their class. This interview took approximately
1 h and covered expectations for the classes and practical
matters. The MBCT course itself was delivered in eight
sessions plus an all-day practice over a period of 9 weeks
(nine attendances in total). The treatment closely followed
the manual of Segal et al. (2002) with the modification that
participants completed an exercise in which they developed
a crisis plan in sessions 6 and 7.
Results
Demographics
Sixty-eight participants (26 men and 42 women) were
recruited to the study. The mean age of the sample was
42 years (SD=10.92, range 22–64). The sample was
generally well educated. Six participants (9%) had left
school without any qualifications, seven (10%) had taken
school leaving exams aged 16, 13 (19%) had completed
further education, 22 (32%) had a degree or equivalent, and
20 (29%) had a postgraduate qualification. Across the
sample as a whole, 29 (43%) individuals were single, 20
(29%) were married, eight (12%) were cohabiting, and nine
(13%) were separated, divorced or widowed. For two
individuals data on marital status was missing.
Clinical History
Episodes of MDD The median number of episodes of
depression reported by participants was 4 (range 1–30). Ten
individuals reported chronic symptoms, with episodes of
depression that were numerous but where the precise
number, could not be determined. The mean reported age
of onset of depressive symptoms was 20 years, the modal
age of onset was 15 years, with approximately 40% of
participants reporting that their first onset of depressed
mood occurred in childhood or adolescence (<16 years).
Suicide Attempts Twenty-six individuals (38%) had made
one or more suicide attempt in the past. Amongst
attempters, the median number of suicide attempts was 1
(range 1–16), with 11 individuals having attempted suicide
only once, 11 having attempted suicide on between two and
five occasions and four having made more than five suicide
attempts.
Medication Usage Thirty-four individuals were taking
psychotropic medication at entry to the trial (data on
medication was missing for two participants). Thirty
individuals were taking one or more antidepressant drug,
two were taking tranquilisers, five were taking antipsychotic
medication, and five were taking lithium or another mood
stabiliser. Several participants were taking multiple medica-
tions at entry.
Psychotherapy Fifty-four participants reported having
received some prior psychotherapy, psychological sup-
port or counselling for depression. Seventeen participants
reported past cognitive behaviour therapy (all with
subsequent relapse to MDD). However in many cases,
the treatment received appeared to have been group-
administered rather than individual and was often of
limited duration (four to six sessions).
Hospitalisation Fifteen participants had received inpatient
treatment for depression or mania in the past (seven with a
single admission, two with two admissions, three with three
admissions and three with five or more admissions).
Baseline Comparisons Between Individuals Allocated
to Immediate and Delayed Treatment
Clinical and Demographic Factors T h e r ew e r en os i g n i -
ficant differences between individuals allocated to imme-
diate and to delayed treatment in age, educational level,
proportion of participants who had attempted suicide,
number of episodes of MDD, age of onset of MDD, prior
inpatient treatment (yes/no), prior psychotherapy, or prior
CBT (all p’s>0.50). The immediate and delayed treatment
group also did not differ in the proportion of participants
taking antidepressant medication at entry (χ
2=0.16, df=1,
p>0.63). The numbers taking tranquilisers, anti-psychotics
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distributed equally across the immediate and delayed groups
(1:1, 2:3 and 2:3 respectively).
Questionnaires The mean score on the BDI-II at
baseline was 12.85 (SD=10.89), approaching the cutoff
for mild depressive symptoms (score of 13). The mean
score on the BAI was 11.56 (SD=9.84). Individuals
allocated to immediate treatment and those allocated to
delayed treatment did not differ significantly from one
another at baseline on the BDI-II or BAI scores. There
were also no differences between the groups on the
BSSw or the Response Styles Questionnaire (RSS) total,
depressive rumination, brooding and reflection subscales
(all p’s≥0.20).
Mood Induction Mood Ratings Visual analogue mood
ratings were taken at four time points during the
experimental session (start, pre-mood induction, post-
mood induction and end). Repeated-measures analysis of
variance (ANOVA) indicated a main effect of time on
ratings of sadness, F(3, 198)=53.91, p<0.001 and
happiness F(3, 198)=28.16, p<0.001, and comparisons
of the means indicated that the mood induction was
effective in producing increases in sadness and decreases
in happiness. There was no significant time×group
interaction, indicating that the mood induction had a
similar effect on those subsequently allocated to immediate
treatment and those in the waitlist condition.
Means End Problem-Solving Task Repeated-measures
analysis of variance was used to examine the effect of
the negative mood induction on problem-solving effec-
tiveness ratings, comparing individuals allocated to
immediate and delayed treatment. There was a trend
towards an effect of time on effectiveness of problem
solving, with participants tending to provide less effec-
tive solutions after the mood induction, F(1, 65)=3.58,
p=0.06, replicating previous findings in suicidal popula-
tions (e.g. Williams et al. 2005). There was no interaction
between time and group, indicating that individuals
allocated to immediate versus delayed treatment were
well matched in cognitive reactivity at baseline.
Word Fluency Analysis indicated no significant main effect
of time, F(1, 66)=2.67, p=0.11, and no time by group
interaction. However there was a significant main effect of
group, F(1, 66)=4.93, p<0.05, with participants allocated
to immediate treatment having superior word fluency at
baseline. These results suggest that the trend towards a
deterioration in problem-solving effectiveness was not
simply the result of decreased verbal fluency following
mood induction.
Levels of Treatment Adherence
One of the primary aims of this trial was to determine
factors affecting the ability of previously suicidal
individuals to participate in MBCT. Participants could
attend a maximum of nine sessions of MBCT (eight
evening classes, plus one all-day practice). Of the 33
individuals randomised to immediate treatment, 23 (70%)
attended four or more sessions of MBCT (defined as a
minimum adequate dose), and ten (30%) dropped out.
The mean number of sessions attended by those
receiving an adequate dose of treatment (i.e. four or
more sessions) was 8.09 (SD=1.20) as compared to 1.50
(SD=1.23) amongst those who did not, indicating that
consistent with previous studies, individuals who
dropped out tended to do so early in treatment, and
those who remained in treatment had very high levels of
adherence.
We first consider baseline factors that differentiated
individuals who were allocated to immediate treatment
and dropped out from those who completed treatment. We
then go on to examine whether factors differentiating
MBCT treatment dropouts from treatment completers also
differentiate waitlist dropouts from individuals in the
waiting list group who remained in the study until the
second assessment. The absence of equivalent differences
between waitlist dropouts and individuals in the waiting list
group who remained in the trial would lend support to the
suggestion that factors distinguishing treatment dropouts
from adherers are related to difficulty with participation in
the treatment itself, rather than to other non-specific factors
affecting participation in a clinical trial.
Factors Related to Attrition from MBCT
Demographic Variables Five men and five women
dropped out, and 11 men and 12 women completed the
treatment, indicating no significant effect of gender.
However individuals who dropped out of treatment were
significantly younger than those who remained in treat-
ment, U=55.00, Z=−2.35, p=0.02.
Clinical Variables There was no significant difference
between those who dropped out and those who completed
treatment in the number of prior episodes of major
depression, a history of manic or hypomanic episodes, the
proportion with lifetime or current alcohol or substance
abuse or dependence or borderline personality disorder. A
greater proportion (n=6, 60%) of treatment dropouts had
attempted suicide as compared to treatment adherers (n=7,
30%) but this difference in proportions was not statistically
significant. Individuals who dropped out were significantly
less likely to be taking antidepressants (n=1, 10%) at
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48%), Fisher’s exact test p=0.05. The low frequencies of
other medications precluded statistical analysis but there
were no apparent differences between groups. Treatment
dropouts did not differ significantly from treatment com-
pleters in the proportion who had previously had psycho-
therapy (n=8, 80% versus n=17, 52%). There was no
difference between the groups in the proportions who had
received cognitive therapy (n=2, 20% versus n=6, 26%).
Finally there was no significant difference between the
dropouts and adherers in terms of hospital admission for
psychiatric problems (n=1, 10% versus n=4, 17%).
Questionnaire Measures No differences between dropouts
and completers were observed on baseline measures of
depression (BDI-II) or anxiety (BAI). However indi-
viduals who dropped out of treatment had a significantly
higher mean score on the measures of depressive
rumination, t(31)=2.32, p=0.03, and brooding, t(31)=
3.48, p=0.002, although they did not differ on the RSS
reflection subscale, p>0.30.
Assessment of Cognitive Reactivity A repeated-measures
ANOVA comparing the effect of negative mood induction
on problem-solving effectiveness in individuals who com-
pleted treatment and those who dropped out revealed a
main effect of time at trend level, F(1, 31)=2.85, p=0.10,
and a significant time×group interaction, F(1, 31)=7.87,
p=0.009. Post hoc tests indicated that whilst individuals who
subsequently dropped out of treatment deteriorated signifi-
cantly (by approximately 20%) in problem-solving effective-
ness from pre- to post-mood induction (p=0.01), those who
subsequently remained in treatment showed no significant
change (see Fig. 2). There were no significant main effects of
group, nor of time×group interactions on the measures of
mood or verbal fluency taken before and after mood
induction. This suggests that the greater vulnerability to
mood-related deteriorations in problem solving amongst
those who dropped out of treatment were unlikely to be
simply the result of more marked shifts in mood, or general
deteriorations in performance on cognitive tasks.
Logistic Regression
In order to determine whether the different factors identified
from univariate analyses independently contributed to the
prediction of dropout from treatment, we conducted a
binary logistic regression analysis with age, antidepressant
use, problem-solving change score and brooding entered
simultaneously into the model as independent variables.
Brooding was selected for entry rather than entering both
brooding and depressive rumination as the two measures
were highly correlated, r (33)=0.57, p=0.001, and brood-
ing more strongly distinguished the groups in the univariate
analyses. The regression model was highly significant,
χ
2(4)=22.61, p<0.001, correctly classifying 90% of par-
ticipants as completers or dropouts. Both effectiveness
change, Wald=4.98, Exp(B)=0.42, df=1, p=0.03 and
brooding, Wald=3.80, Exp(B)=0.61, df=1, p=0.05 were
significant independent predictors of dropout. Age and
antidepressant use did not contribute significantly to the
model in the context of the other variables.
Factors Related to Dropout from the Waitlist Condition
To explore whether the differences observed between those
who remained in treatment and those who dropped out
related to the acceptability of treatment, rather than
participation in the research elements of the trial, we
compared the variables found to be related to attrition from
treatment between individuals who were allocated to the
waiting list condition who did, n=27, or did not n=8 attend
the follow-up assessment session. Due to the very small
numbers being compared, these analyses should clearly be
interpreted tentatively.
Comparisons Non-parametric comparisons between the
groups revealed no significant differences on the RSS
rumination (p=0.59) and brooding (p=0.35) subscales
between those participants who remained in the waitlist
arm of the trial and those who dropped out. Similarly a
repeated-measures ANOVA indicated that whilst effective-
ness deteriorated somewhat in both groups from pre- to
post-mood induction, this effect did not reach statistical
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effect of group and no time×group interaction. However
inspection of the mean scores pre- and post-mood induction
revealed that in the waiting list condition, the effect of the
mood induction was slightly more pronounced in those who
remained in the study.
Discussion
Although the majority of previous trials of MBCT and
MBSR have compared those who dropped out to those who
completed treatment in terms of baseline characteristics,
very few factors have been identified that predict attrition to
date. Additionally, where factors have been identified, these
usually relate to socio-demographic characteristics or
clinical history rather than to proximal cognitive factors,
which might guide the modification of treatment for those
at risk of dropout. In this paper, we explored predictors of
attrition in patients with a history of suicidal depression
randomly allocated to treatment with MBCT as part of a
feasibility trial exploring the usefulness of MBCT for
patients with a history of suicidal ideation or behaviour.
Since these patients may be particularly at risk of dropout
from treatment, identification of variables which might
predict attrition and which might be amenable to compen-
satory efforts on the part of the therapist is crucial.
Almost one third of patients (30%) dropped out of
MBCT, having attended fewer than four classes, a higher
percentage than observed in previous trials of MBCT that
had enrolled previously depressed patients unselected for
history of suicidality (e.g. Ma and Teasdale 2004; Kuyken
et al. 2008; Teasdale et al. 2000). More consistent with
previous findings, however, was the observation that where
dropout occurred, it tended to do so very early in treatment
(in most cases before treatment had started, or after only
one session). We identified a number of variables that
predicted attrition: levels of depressive rumination and
brooding (higher levels associated with greater dropout),
age (those who were young relative to the average for
participants in class were more at risk), antidepressant
medication (those not taking medication were more at risk)
and increased cognitive reactivity to sad mood (those who
showed greater deteriorations in problem-solving perfor-
mance were more likely to drop out). Logistic regression
analysis, to explore the predictive capacity of each of the
variables identified in the univariate analysis in parallel,
indicated that both brooding and cognitive reactivity had
significant independent effects on dropout. None of the
factors that differentiated MBCT treatment completers from
dropouts distinguished completers and dropouts in the
waitlist arm of the trial, lending some support to the
suggestion that these variables may relate more closely to
difficulties with the experience (or prospect) of treatment
itself than to more generic aspects of compliance with the
research protocol.
Given the relatively small sample size, any conclusions
must be tentative. However our observation that individuals
who have high levels of cognitive reactivity find it more
difficult to engage with MBCT does makes theoretical
sense. Cognitive reactivity describes the process by which
small changes in mood rapidly activate depressogenic
cognitions and behavioural deficits. Patients with high
levels of cognitive reactivity are likely to be more
frequently confronted with distressing thoughts and feelings
and less able to respond in a way which is adaptive, when
they occur. Mindfulness training requires direct and
sustained contact with all experience and so is likely to
bring these aversive experiences into sharp relief, earlier in
the process of treatment than might be the case for patients
with less reactive profiles. Similarly those who typically
respond to unwanted experiences with brooding are invited
to relinquish their habitual responses from the outset of
treatment, before they have had the opportunity to
experience the benefits of this approach directly. Research
in substance abuse populations shows that low levels of
psychological distress tolerance predict early dropout from
treatment (Daughters et al. 2005), and it would be
interesting in future research to explore the extent to which
the same is true of MBCT.
The identification of people who are likely to have
difficulties engaging with treatment may be beneficial, and
whilst it is not practical to conduct mood inductions in
routine clinical practice, careful questioning of participants
may be able to identify those whose responses to low mood
are characterised by cognitive reactivity and impairments in
functioning. Indeed the measure of emotional role func-
tioning, which differentiated dropouts from treatment
completers in Lynch (2004), may capture the type of
deterioration in problem solving identified in the current
study since it is described as a measure of ‘perceived
limitations in role functioning due to emotional factors’
(p. 47), e.g. the inability to functioning effectively when
experiencing emotional distress.
It is our observation that if mindfulness teachers are able,
during their pre-class interview, to discuss in detail the
rationale for treatment (and why reducing levels of
rumination is likely to be helpful), establish realistic
expectations (that early mindfulness practices will be
challenging and may include the experience of distressing
emotions) and provide some strategies for how to respond
if such emotions do arise (for example discussing ground-
ing techniques, encouraging contact with the teacher between
classes and emphasising the need for perseverance); these can
enhance motivation and increase persistence when difficulties
18 Mindfulness (2010) 1:10–20do arise. Most mindfulness teachers are likely to cover some
or all of this information in their pre-class interviews.
However identifying the people for whom this is likely to be
most critical and monitoring their progress in early classes
may help.
Two other factors were identified in univariate analyses,
and given the exploratory nature of the study, we discuss
them briefly. First, those who dropped out were signifi-
cantly less likely to be on antidepressants that those who
completed treatment. All participants had a history of
depression, the majority with several prior episodes
(median of 4). Since maintenance antidepressants are
recommended for all people with such a history (NICE
2009), it is possible that the fact that these patients were not
on antidepressants is a sign of lack of engagement with
treatment in general. Alternatively it is possible that
antidepressant medication stabilises people, enabling them
to then benefit more from MBCT, at least at the outset.
Further research examining differential responding to
MBCT in patients on and off antidepressant medication,
matched for other clinical history variables, would shed
light on this issue.
Age was the final factor which distinguished the dropouts
from the completers. A similar finding has been observed for
dropout from personality disorder services (Crawford et al.
2009) with whom our population of previously suicidal
patients may have some overlap. One possibility is that
individuals who were younger than average felt less able to
relate to other members of the group, or felt themselves to be
more of an outsider. The support provided by the group and
the realisation of not being alone in suffering from
depression have been repeatedly identified as core to the
experience of MBCT in qualitative studies (e.g. Mason and
Hargreaves 2001; Allen et al. 2009). It is possible that
participants who are much younger than average have less of
a sense of shared experience with other group members.
They may also have a shorter history of depressive illness
and hence be less motivated to engage in an intensive
treatment intervention. However it is possible that the effect
relates to a few younger participants who differed in some
other respect, not identified here.
The most obvious limitation of our study is the small
sample size on which comparisons between dropouts and
treatment completers are based. This is a limitation which
faces most analyses of dropout from treatment, and may
account for the fact that often few significant differences
are observed. Indeed only because there was relatively high
dropout in this trial were such comparisons possible. In
view of this, our results must be interpreted tentatively, as
suggestions for future research rather than definite prog-
nostic indicators. Additionally these data were obtained
from a clinical trial of MBCT rather than from routine
clinical practice. The disadvantage is that some of the
factors that might be expected to relate to attrition, such as
variations in general motivation to obtain treatment or
household income (e.g. Warden et al. 2009), might be less
relevant, since expenses to attend the research trial were
reimbursed and participants were relatively highly motivat-
ed at the outset, in most cases having referred themselves to
the trial directly. However, if such factors are removed or
diminished in importance, this may allow for the identifi-
cation of other variables, which would otherwise be missed.
Despite these caveats, we do believe that the results are
of interest. Firstly, they suggest the existence of variables
which relate meaningfully to risk processes and which
simultaneously influence engagement in treatment. In this
trial, participants with the highest levels of cognitive
vulnerability were most likely to drop out of treatment
before receiving an adequate dose. It is therefore likely to
be essential to target these risk processes and the impact
that they have on engagement with treatment, if the efficacy
of treatments is to be enhanced. Secondly, this study
suggests that the identification of proximal psychological
variables, which predict dropout, is possible, although few
studies look beyond clinical and demographic variables
when examining attrition.
In our current trial for preventing suicidal depression, we
give particular attention to addressing the factors that might
predict dropout by giving an extended pre-class interview
to the most vulnerable participants, and the early indica-
tions are that the proportion of those dropping out has fallen
markedly as a result. We encourage other researchers to
consider exploring factors associated with attrition in more
detail, since the findings have not only direct clinical
implications but also the potential to tell us much about the
processes involved in the acquisition of mindfulness skills.
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